Pain Management in Multiple Myeloma Patients: A Literature Review

Overview

Journal Cureus

Specialty Biomedical Engineering

Date 2024 Apr 11

PMID 38601412

Authors

Shubh Rana

Suprina Maharjan

Shanisha D Sookdeo

Patrik Schmidt

Affiliations

Soon will be listed here.

Abstract

Managing pain in cancer patients with multiple myeloma (MM) poses a considerable challenge. This review thoroughly investigates current pain management strategies, difficulties, and future directions in the field. The review divides pain treatment strategies into pharmaceutical and non-pharmacological therapies. Looking ahead, promising areas for future study and development are mentioned, such as incorporating precision medicine into pain management and investigating innovative therapeutics. Despite existing limitations, advances in pain management provide great opportunities to improve the quality of life and overall results for MM patients.

Citing Articles

Unmasking Multiple Myeloma: The Importance of Suspecting Malignancy in Atypical Chronic Pain Mimicking Degenerative Conditions-A Case Report.

Mo B, Sacks S, Markar J Clin Case Rep. 2025; 13(1):e70129.

PMID: 39822886 PMC: 11736700. DOI: 10.1002/ccr3.70129.

References

Belcher S, Bruner D, Hofmeister C, Kweon J, Meghani S, Yeager K . Characterizing Pain Experiences: African American Patients With Multiple Myeloma Taking Around-the-Clock Opioids. Clin J Oncol Nurs. 2020; 24(5):538-546. PMC: 10432153. DOI: 10.1188/20.CJON.538-546. View

Ahmedzai S . Current strategies for pain control. Ann Oncol. 1997; 8 Suppl 3:S21-4. DOI: 10.1093/annonc/8.suppl_3.s21. View

Pozzi S, Bari A, Pecherstorfer M, Vallet S . Management of Adverse Events and Supportive Therapy in Relapsed/Refractory Multiple Myeloma. Cancers (Basel). 2021; 13(19). PMC: 8508369. DOI: 10.3390/cancers13194978. View

Tsai C, Lin Y, Li Y, Ho T, Thuong L, Liu Y . Integrated Medicine for Chemotherapy-Induced Peripheral Neuropathy. Int J Mol Sci. 2021; 22(17). PMC: 8430591. DOI: 10.3390/ijms22179257. View

Goldstein D . Denosumab for bone lesions in multiple myeloma - what is its value?. Haematologica. 2018; 103(5):753-754. PMC: 5927995. DOI: 10.3324/haematol.2017.185264. View

Singh H, Banipal R, Singh B . Assessment of Adequacy of Pain Management and Analgesic Use in Patients With Advanced Cancer Using the Brief Pain Inventory and Pain Management Index Calculation. J Glob Oncol. 2017; 3(3):235-241. PMC: 5493218. DOI: 10.1200/JGO.2016.004663. View

Nersesyan H, Slavin K . Current aproach to cancer pain management: Availability and implications of different treatment options. Ther Clin Risk Manag. 2008; 3(3):381-400. PMC: 2386360. View

Trentham-Dietz A, Corley D, Del Vecchio N, Greenlee R, Haas J, Hubbard R . Data gaps and opportunities for modeling cancer health equity. J Natl Cancer Inst Monogr. 2023; 2023(62):246-254. PMC: 11009506. DOI: 10.1093/jncimonographs/lgad025. View

Boland E, Eiser C, Ezaydi Y, Greenfield D, Ahmedzai S, Snowden J . Living with advanced but stable multiple myeloma: a study of the symptom burden and cumulative effects of disease and intensive (hematopoietic stem cell transplant-based) treatment on health-related quality of life. J Pain Symptom Manage. 2013; 46(5):671-80. DOI: 10.1016/j.jpainsymman.2012.11.003. View

10.

Stout N, Santa Mina D, Lyons K, Robb K, Silver J . A systematic review of rehabilitation and exercise recommendations in oncology guidelines. CA Cancer J Clin. 2020; 71(2):149-175. PMC: 7988887. DOI: 10.3322/caac.21639. View

11.

Branagan A, Lei M, Lou U, Raje N . Current Treatment Strategies for Multiple Myeloma. JCO Oncol Pract. 2020; 16(1):5-14. DOI: 10.1200/JOP.19.00244. View

12.

Nathwani N, Bell J, Cherepanov D, Ginchereau Sowell F, Shah R, McCarrier K . Patient perspectives on symptoms, health-related quality of life, and treatment experience associated with relapsed/refractory multiple myeloma. Support Care Cancer. 2022; 30(7):5859-5869. PMC: 9135799. DOI: 10.1007/s00520-022-06979-7. View

13.

Scarborough B, Smith C . Optimal pain management for patients with cancer in the modern era. CA Cancer J Clin. 2018; 68(3):182-196. PMC: 5980731. DOI: 10.3322/caac.21453. View

14.

Shi H, Ren H, Tian Y, Chen Z, Xu C, Lu L . Pain as a risk factor of depression and anxiety symptoms with multiple myeloma during maintenance therapy. Front Psychol. 2022; 13:1015497. PMC: 9748158. DOI: 10.3389/fpsyg.2022.1015497. View

15.

Fallon M, Giusti R, Aielli F, Hoskin P, Rolke R, Sharma M . Management of cancer pain in adult patients: ESMO Clinical Practice Guidelines. Ann Oncol. 2018; 29(Suppl 4):iv166-iv191. DOI: 10.1093/annonc/mdy152. View

16.

Ludwig H, Bailey A, Marongiu A, Khela K, Milligan G, Carlson K . Patient-reported pain severity and health-related quality of life in patients with multiple myeloma in real world clinical practice. Cancer Rep (Hoboken). 2021; 5(1):e1429. PMC: 8789609. DOI: 10.1002/cnr2.1429. View

17.

Katz N . The impact of pain management on quality of life. J Pain Symptom Manage. 2002; 24(1 Suppl):S38-47. DOI: 10.1016/s0885-3924(02)00411-6. View

18.

Niscola P, Scaramucci L, Romani C, Giovannini M, Tendas A, Brunetti G . Pain management in multiple myeloma. Expert Rev Anticancer Ther. 2010; 10(3):415-25. DOI: 10.1586/era.10.5. View

19.

Miceli T, Gonsalves W, Buadi F . Supportive care in multiple myeloma: Current practices and advances. Cancer Treat Res Commun. 2021; 29:100476. PMC: 8688260. DOI: 10.1016/j.ctarc.2021.100476. View

20.

Bylund C, Eggly S, LeBlanc T, Kurtin S, Gandee M, Medhekar R . Survey of patients and physicians on shared decision-making in treatment selection in relapsed/refractory multiple myeloma. Transl Behav Med. 2023; 13(4):255-267. DOI: 10.1093/tbm/ibac099. View